Zoetis Ownership
ZTS Stock | USD 176.74 1.04 0.59% |
Shares in Circulation | First Issued 2011-03-31 | Previous Quarter 456 M | Current Value 453.5 M | Avarage Shares Outstanding 485.4 M | Quarterly Volatility 14.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Zoetis |
Zoetis Stock Ownership Analysis
About 96.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.45. Zoetis Inc recorded earning per share (EPS) of 5.36. The entity last dividend was issued on the 31st of October 2024. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis Inc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 12100 people. For more information please call Kristin Peck at 973 822 7000 or visit https://www.zoetis.com.Besides selling stocks to institutional investors, Zoetis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Zoetis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Zoetis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Zoetis Quarterly Liabilities And Stockholders Equity |
|
Zoetis Insider Trades History
Less than 1% of Zoetis Inc are currently held by insiders. Unlike Zoetis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Zoetis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Zoetis' insider trades
Zoetis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zoetis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zoetis Inc backward and forwards among themselves. Zoetis' institutional investor refers to the entity that pools money to purchase Zoetis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Polen Capital | 2024-09-30 | 6.4 M | Northern Trust Corp | 2024-09-30 | 5.7 M | Norges Bank | 2024-06-30 | 5 M | Mizuho Securities Usa Inc | 2024-09-30 | 4.9 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 4.8 M | Nuveen Asset Management, Llc | 2024-06-30 | 4.8 M | Goldman Sachs Group Inc | 2024-06-30 | 4.7 M | Bank Of New York Mellon Corp | 2024-06-30 | 4.7 M | Unisphere Establishment | 2024-09-30 | 4.5 M | Vanguard Group Inc | 2024-09-30 | 41.2 M | Blackrock Inc | 2024-06-30 | 36.8 M |
Zoetis Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zoetis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zoetis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zoetis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ashton Nicholas over six months ago Acquisition by Ashton Nicholas of 283 shares of Zoetis subject to Rule 16b-3 | ||
Roman Trawicki over a year ago Exercise or conversion by Roman Trawicki of 6402 shares of Zoetis subject to Rule 16b-3 |
Zoetis' latest congressional trading
Congressional trading in companies like Zoetis Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Zoetis by those in governmental positions are based on the same information available to the general public.
2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
2024-08-19 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
2024-08-06 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
2024-05-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2024-04-30 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2024-03-15 | Senator Shelley Moore Capito | Acquired $15K to $50K | Verify | ||
2024-03-14 | Senator Shelley Moore Capito | Acquired $15K to $50K | Verify | ||
2024-01-26 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2024-01-25 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2023-11-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2023-10-12 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify |
Zoetis Outstanding Bonds
Zoetis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zoetis Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zoetis bonds can be classified according to their maturity, which is the date when Zoetis Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
US98971DAB64 Corp BondUS98971DAB64 | View | |
US989701BD83 Corp BondUS989701BD83 | View | |
ZOETIS INC 395 Corp BondUS98978VAM54 | View | |
ZOETIS INC 39 Corp BondUS98978VAN38 | View | |
ZOETIS INC 45 Corp BondUS98978VAK98 | View | |
ZOETIS INC 3 Corp BondUS98978VAL71 | View | |
ZOETIS INC Corp BondUS98978VAS25 | View | |
ZOETIS INC 445 Corp BondUS98978VAP85 | View |
Zoetis Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 14th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 4th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
26th of June 2024 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Zoetis Stock Analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.